Reporter
Informatics team creates gene app, wins national contest
Dec. 9, 2011—Members of informatics team have been recognized by National Library of Medicine for gene app.
Exercise fights fatty liver
Nov. 18, 2011—Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a hormone that raises blood glucose levels)...
Skeletal defects in genetic disorder
Nov. 18, 2011—A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis.
Averting a future oncologist shortage
Nov. 11, 2011—Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.
Balancing act in the gut
Nov. 11, 2011—Vanderbilt researchers have identified an antigen important to balancing the immune response to bacteria in the gut.
Breastfeeding problems can be linked to a tied tongue
Nov. 10, 2011—A simple procedure can correct ‘tongue-tie,’ a commonly missed condition that could prevent newborns from breastfeeding properly.
Let there be light and melatonin
Nov. 4, 2011—Light and the hormone melatonin may play important roles in the developing brain.
Vanderbilt study finds no heart risk in ADHD medications
Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.
Lung disorder drug regimen found harmful
Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.
Protein family key to aging linked to suppressing tumors
Oct. 28, 2011—The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.
Vanderbilt doctors to screen patients taking statins for genetic risk factors
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Stopping colitis, STAT
Oct. 27, 2011—Study suggests a new therapeutic target in ulcerative colitis.
